Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Alto Neuroscience, Inc. (ANRO) Institutional Ownership & Insider Trading

114 institutions reported holding Alto Neuroscience, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 3 insider trades on Form 4.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ANROAlto Neuroscience, Inc.Follow ANRO — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
862.1M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

114 institutions held 75.1% of the shares. Across filers that reported both quarters, shares held changed +9.8%.

Increased+36New+25Decreased-24Closed-21

Largest moves, shares (millions)

BlackRock+1.5MAdage Capital Partners Gp+1.2MState Street+0.5MVestal Point Capital-1.3MPerceptive Advisors-0.4MJennison Associates-0.4M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Sep 24-0.4Dec 24-1.6Mar 25-3.6Jun 25-0.4Sep 25+7.7Dec 25+2.5Mar 26+2.6Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2611429+9.8%36252421
Mar 2611027+10.8%2721378
Dec 259624+46.8%2626247
Sep 257717-2.1%1762410
Jun 257917-17.5%21172322
Mar 258321-7.3%1618259
Dec 247723-1.9%30211021
Sep 247423—————

Alto Neuroscience, Inc. — questions

Who owns Alto Neuroscience, Inc. stock?
114 institutions reported Alto Neuroscience, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Alpha Wave Global, LP (9.4%), Commodore Capital LP (6.9%), BlackRock, Inc. (5.4%).
Are Alto Neuroscience, Inc. insiders buying or selling?
3 insider trades on Form 4; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Alto Neuroscience, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.